Clinical trials
Completed Recurrence trials in Serbia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2009 | 4 |
| 2011 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 5 |
| AstraZeneca | 1 |
| Eli Lilly and Company | 1 |
| Genzyme, a Sanofi Company | 1 |
| Hoffmann-La Roche | 1 |
| Karyopharm Therapeutics Inc | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
| Teva Branded Pharmaceutical Products R&D, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 13 |
| Multiple Sclerosis | 6 |
| Multiple Sclerosis, Relapsing-Remitting | 4 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Head and Neck Neoplasms | 1 |
| Leukemia | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Lymphoma | 1 |
| Lymphoma, Large B-Cell, Diffuse | 1 |
| Lymphoma, Non-Hodgkin | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.